<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font28 { font-size : 28; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">vaccine </span>
   <span class="font29">CEPI </span>
   <span class="font28">development </span>
   <span class="font23">vaccines </span>
   <span class="font21">clinical </span>
   <span class="font20">million </span>
   <span class="font17">{border-style </span>
   <span class="font16">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">Lassa </span>
   <span class="font16">trials </span>
   <span class="font16">virus </span>
   <span class="font15">phase </span>
   <span class="font15">US$. </span>
   <span class="font15">diseases </span>
   <span class="font15">efficacy </span>
   <span class="font15">global </span>
   <span class="font15">candidates </span>
   <span class="font15">trial </span>
   <span class="font14">Research </span>
   <span class="font14">infectious </span>
   <span class="font14">Preclinical </span>
   <span class="font14">animal </span>
   <span class="font14">epidemic </span>
   <span class="font14">research </span>
   <span class="font14">support </span>
   <span class="font14">Coalition </span>
   <span class="font14">EIDs </span>
   <span class="font14">Health </span>
   <span class="font14">Preparedness </span>
   <span class="font14">potential </span>
   <span class="font14">priority </span>
   <span class="font14">product </span>
   <span class="font14">studies </span>
   <span class="font13">Epidemic </span>
   <span class="font13">US$ </span>
   <span class="font13">collab: </span>
   <span class="font13">fever </span>
   <span class="font13">funding </span>
   <span class="font13">health </span>
   <span class="font13">manufacturing </span>
   <span class="font13">outbreak </span>
   <span class="font13">outbreaks </span>
   <span class="font13">standards </span>
   <span class="font13">Ebola </span>
   <span class="font13">International </span>
   <span class="font13">Phase </span>
   <span class="font13">R&amp;amp;D </span>
   <span class="font13">accelerate </span>
   <span class="font13">recombinant </span>
   <span class="font13">response </span>
   <span class="font13">und </span>
   <span class="font13">von </span>
   <span class="font12">CEPIâ€™s </span>
   <span class="font12">MERS-CoV </span>
   <span class="font12">Multiyear </span>
   <span class="font12">Nipah </span>
   <span class="font12">Recombinant </span>
   <span class="font12">capacity </span>
   <span class="font12">data </span>
   <span class="font12">die </span>
   <span class="font12">emerging </span>
   <span class="font12">epidemiological </span>
   <span class="font12">human </span>
   <span class="font12">new </span>
   <span class="font12">px; </span>
   <span class="font12">regulatory </span>
   <span class="font12">{font-family </span>
   <span class="font12">Chikungunya </span>
   <span class="font12">EIDs, </span>
   <span class="font12">Global </span>
   <span class="font12">National </span>
   <span class="font12">World </span>
   <span class="font12">advance </span>
   <span class="font12">font-size </span>
   <span class="font12">future </span>
   <span class="font12">partnership </span>
   <span class="font12">pathogen </span>
   <span class="font12">process </span>
   <span class="font12">provide </span>
   <span class="font12">(CEPI) </span>
   <span class="font12">Innovations </span>
   <span class="font12">MERS-CoV, </span>
   <span class="font12">Rift </span>
   <span class="font12">Valley </span>
   <span class="font12">countries </span>
   <span class="font12">current </span>
   <span class="font12">currently </span>
   <span class="font12">der </span>
   <span class="font12">development, </span>
   <span class="font12">double; </span>
   <span class="font12">international </span>
   <span class="font12">prevent </span>
   <span class="font12">risk </span>
   <span class="font12">testing </span>
   <span class="font12">used </span>
   <span class="font12">year </span>
   <span class="font11">Biological </span>
   <span class="font11">Blueprint </span>
   <span class="font11">Dis </span>
   <span class="font11">Disease </span>
   <span class="font11">European </span>
   <span class="font11">Gates </span>
   <span class="font11">Infect </span>
   <span class="font11">Institute </span>
   <span class="font11">Melinda </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Nipah, </span>
   <span class="font11">Organization </span>
   <span class="font11">Vaccine </span>
   <span class="font11">Vaccines </span>
   <span class="font11">appropriate </span>
   <span class="font11">article </span>
   <span class="font11">auf </span>
   <span class="font11">available </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">collaboration </span>
   <span class="font11">coronavirus </span>
   <span class="font11">develop </span>
   <span class="font11">diagnostic </span>
   <span class="font11">disease, </span>
   <span class="font11">economic </span>
   <span class="font11">efforts </span>
   <span class="font11">endemic </span>
   <span class="font11">establishing </span>
   <span class="font11">including </span>
   <span class="font11">investigational </span>
   <span class="font11">investments </span>
   <span class="font11">needed </span>
   <span class="font11">pathogens </span>
   <span class="font11">preclinical </span>
   <span class="font11">projects </span>
   <span class="font11">related </span>
   <span class="font11">respiratory </span>
   <span class="font11">safety </span>
   <span class="font11">science </span>
   <span class="font11">site </span>
   <span class="font11">solid; </span>
   <span class="font11">target </span>
   <span class="font11">technologies </span>
   <span class="font11">unknown </span>
   <span class="font11">viruses </span>
   <span class="font11">work </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">Animal </span>
   <span class="font11">Collaboration </span>
   <span class="font11">Commission </span>
   <span class="font11">Development </span>
   <span class="font11">Hatchett </span>
   <span class="font11">However, </span>
   <span class="font11">III </span>
   <span class="font11">Innovation </span>
   <span class="font11">Lassa, </span>
   <span class="font11">Reduction </span>
   <span class="font11">University </span>
   <span class="font11">West </span>
   <span class="font11">[], </span>
   <span class="font11">activities </span>
   <span class="font11">affected </span>
   <span class="font11">aim </span>
   <span class="font11">and, </span>
   <span class="font11">antibody </span>
   <span class="font11">antigens </span>
   <span class="font11">assays </span>
   <span class="font11">billion </span>
   <span class="font11">biological </span>
   <span class="font11">bold </span>
   <span class="font11">candidate </span>
   <span class="font11">case </span>
   <span class="font11">coordinate </span>
   <span class="font11">courier; </span>
   <span class="font11">developed </span>
   <span class="font11">developing </span>
   <span class="font11">development. </span>
   <span class="font11">disease </span>
   <span class="font11">eine </span>
   <span class="font11">em; </span>
   <span class="font11">enable </span>
   <span class="font11">essential </span>
   <span class="font11">established </span>
   <span class="font11">ethical </span>
   <span class="font11">evaluation </span>
   <span class="font11">feasibility </span>
   <span class="font11">field </span>
   <span class="font11">impact </span>
   <span class="font11">innovative </span>
   <span class="font11">investment </span>
   <span class="font11">make </span>
   <span class="font11">multiple </span>
   <span class="font11">need </span>
   <span class="font11">needs </span>
   <span class="font11">nucleic </span>
   <span class="font11">original </span>
   <span class="font11">pathogens, </span>
   <span class="font11">people </span>
   <span class="font11">platform </span>
   <span class="font11">platforms </span>
   <span class="font11">portfolio </span>
   <span class="font11">proteins. </span>
   <span class="font11">pt;} </span>
   <span class="font11">public </span>
   <span class="font11">rapid </span>
   <span class="font11">reduce </span>
   <span class="font11">reference </span>
   <span class="font11">strengthening </span>
   <span class="font11">successful </span>
   <span class="font11">supporting </span>
   <span class="font11">threats </span>
   <span class="font11">trials, </span>
   <span class="font11">use </span>
   <span class="font11">using </span>
   <span class="font11">variety </span>
   <span class="font11">virus, </span>
   <span class="font11">world </span>
  </p>
 </body>
</html>
